Life Science Tech Startup Investment Readiness Excel Tool
A small thank-you to founders, scientists, and innovators using this tool to build stronger, more fundable life science companies.
If you are building a life science tech, techbio, diagnostics, or platform company, understanding your Life Science Tech Startup Investment Readiness is essential. Many founders underestimate or misjudge their level of preparedness for investors. This Life Science Tech Startup Investment Readiness Excel Tool gives you a clear, structured, and investor-aligned way to evaluate where you stand and what you must improve to become fundable.
Whether you are preparing for your first Seed round or optimizing for Series A, this tool helps you see your company through the lens of investors—so you can focus your time and resources on the gaps that matter most.
What Is the Life Science Tech Startup Investment Readiness Excel Tool?
The Life Science Tech Startup Investment Readiness Excel Tool is a practical, easy-to-use assessment framework built specifically for founders in the life science tech and techbio ecosystem. It turns investor expectations into a transparent checklist, giving you both a diagnostic snapshot and a roadmap toward investment readiness.
When you purchase the tool, you receive an Excel file with three structured tabs:
1️⃣ Cover Page
A simple overview that explains how to use the tool effectively. You’ll know exactly where to start and how to interpret the different sections.
2️⃣ Assessment Spreadsheet (14 Investor-Critical Categories)
- Evaluate your startup across the 14 dimensions investors consistently care about, including:
- Team & Leadership
- Technology Validation
- Market Understanding
- IP Strategy
- Competition & Differentiation
- Regulatory Pathway
- Go-to-Market Strategy
- Financial Model
- Data Strategy
- Commercial Potential
- Partnerships & Ecosystem Signals
- Risk Mitigation
- Operational Readiness
- Vision & Long-Term Potential
Each category includes a clear scoring framework, explanation of criteria, and short guides to help you assess your company honestly and consistently.
3️⃣ Scoring & Simulation Dashboard
Input your scores and immediately see:
- Your overall Life Science Tech Startup Investment Readiness score
- Strengths and gaps across all 14 categories
- Quick simulations showing how improvements in specific areas change your overall readiness
- A visual representation of your current stage and the effort required to reach the next milestone
This instantly highlights where high-leverage improvements exist—and what matters most before speaking with investors.
Who This Is For
This tool is designed for:
- Founders of techbio, life science tools, diagnostics, and platform companies preparing for Seed or Series A
- Scientists turning breakthrough research into a mission-driven business
- Innovation teams inside accelerators and incubators
- Advisors guiding early-stage teams through their fundraising journey
If you want clarity, structure, and investor-aligned insight, this tool delivers it without overwhelm or fluff.
What You’ll Achieve
✔️ A realistic view of your investment readiness
✔️ A prioritized roadmap for improving your fundability
✔️ A stronger, more coherent pitch and fundraising narrative
✔️ Increased confidence before investor meetings
✔️ Better internal alignment and decision-making
✔️ A structured way to track progress over time
This isn’t just an assessment—it becomes part of your internal strategy toolkit.
How It Works
- Purchase and instantly download the Excel file.
- Complete the self-assessment (30–60 minutes).
- Review your scoring dashboard and identify areas with the biggest impact.
- Use the insights to refine your pitch deck, data room, and business strategy.
- Reassess periodically to track your progress toward full investment readiness.
👉 Get Your Life Science Tech Startup Investment Readiness Score Today.
Digital Download: Excel (.xlsx)
Instant access. Zero fluff. Ready when you are.
About the Creator
Developed by Dr. Fabio D’Agostino (over 15 years in the life science and biotech industry, as a scientist, VC and start-ups advisor, consultant to PE firms and CDMOs, and M&A strategist) and reviewed by VC experienced professionals who invested millions into therapeutics companies in the US, EU and China:
Reviewers:
- Margherita Marchetti (Investment Director, Innovation Industries)
- Kjell Mortier (Fund Manager, Novalis Biotech),
- Joey Mason (Former Investment Director at M Ventures, now Venture Partner at Claret Capital Partners),
- Bryan Poltilove (Independent Consultant, Former Operating Partner at BroadOak Capital Partners)
Have questions about your project?
Click here to book a call. I’m happy to help.
